Journal
EXPERT REVIEW OF NEUROTHERAPEUTICS
Volume 12, Issue 4, Pages 461-473Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1586/ERN.12.23
Keywords
attention-deficit/hyperactivity disorder; autism; autism spectrum disorders; hyperactivity; inattention; methylphenidate; pervasive developmental disorders; pharmacological treatment; psychostimulants
Categories
Ask authors/readers for more resources
We conducted a comprehensive review of studies assessing the efficacy and tolerability of psychostimulants for ADHD-like symptoms in individuals with autism spectrum disorder (encompassing autism disorder, Asperger's syndrome and pervasive developmental disorders not otherwise specified). PubMed, Ovid, EMBASE, Web of Science, ERIC and CINHAL were searched through 3 January 2012. From a pool of 348 potentially relevant references, 12 citations (11 studies) were retained as pertinent. Four of the included studies had a randomized controlled design. Most of the studies assessed methylphenidate immediate release. Despite inter-study heterogeneity, taken together, the results of the selected reports suggest that psychostimulants may be effective for ADHD-like symptoms in autism spectrum disorder individuals. The most common adverse events reported in the included trials were appetite reduction, sleep-onset difficulties, irritability and emotional outbursts. We discuss future directions in the field, including the need for trials assessing more ecological outcomes and combined treatment strategies tailored to the specific individual features.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available